On Thursday, Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), added 0.35% and closed at $22.77 in the last trading session. The last trading range of the stock ranges between $21.84 and $22.79. Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) recently declared that Louis W. Yu, Ph.D. has been designated to the newly created position of Chief Quality Officer, Global Quality, effective October 3, 2016.
Dr. Yu will report to Joseph C. Papa, Chairman and CEO of Valeant. As a new member of Valeant’s Executive Committee, Dr. Yu will oversee all aspects of quality and regulatory compliance for all of Valeant’s global businesses and operating sites.
Dr. Yu joins Valeant with more than 30 years of leadership experience in the Quality and R&D functions of generic and branded pharmaceutical companies. He was Executive Vice President, Global Quality & Compliance at The Perrigo Company from November 2006 to January 2016, where he was responsible for planned leadership and regulatory compliance in addition to the global patient safety/medical affairs departments. He also served between May and September 2016 as the Senior Vice President, Global Quality and Compliance at AMRI, a contract development and manufacturing organization (CDMO) company.
“Delivering quality products leads to quality health outcomes, and that is what we are focused on at Valeant,” said Joseph C. Papa, chief executive officer of Valeant. “Dr. Louis Yu is a great addition to our organization, and we are delighted to bring him into the company in the important new role of Chief Quality Officer. Dr. Yu’s deep quality leadership experience at a number of branded and generic pharmaceutical companies gives him a deep understanding of what our customers and regulators need, and I look forward to working closely with him.”
Host Hotels and Resorts Inc (NYSE:HST), dropped -0.45% and closed at $15.49 in the last trading session. The last trading range of the stock ranges between $15.37 and $15.83. The company’s Market capitalization is $11.46 Billion with the total outstanding Shares of 742.48 million. Host Hotels & Resorts, Inc. is a publicly owned real estate investment trust (REIT). The firm mainly engages in the ownership and operation of hotel properties. It invests in the real estate markets of United States. It also invests in Canada, Mexico, Chile, the United Kingdom, Italy, Spain, and Poland. The firm mainly invests in luxury and upper upscale hotels.
Eli Lilly and Co (NYSE:LLY), Dropped -0.66% and closed at $80.00 in the last trading session. The last trading range of the stock ranges between $79.60 and $80.49. During the 52-week trading session the minimum price at which share price traded, registered at $67.88 and reached to max level of $88.16. HMS Holdings Corp. (HMSY) recently declared that Alex Michael Azar II has been designated to the HMS Board of Directors, effective October 11, 2016. Mr. Azar is President, Lilly USA, LLC, the leading associate of Eli Lilly & Company (LLY). Before joining Lilly, Mr. Azar was the Deputy Secretary (2005-2007) and General Counsel (2001-2005) at the U.S. Department of Health & Human Services.
“Alex Azar brings an important blend of government and industry experience to our Board,” said Bill Lucia, Chairman and CEO. “He has an informed perspective on healthcare policy which will enrich our Board dialogue. In addition, Alex has extensive experience with big data in his current role at Lilly which is particularly relevant as we expand into the care administration and data analytics field with our recent acquisition of Essette.”
Before his service at HHS, Mr. Azar was in private legal practice. He is a graduate of Dartmouth College and the Yale Law School, and was a Law Clerk to U.S. Supreme Court Justice Antonin Scalia.